India, Feb. 6 -- Mumbai-based Apex Kidney Care (AKC) has received $9 million in Foreign Direct Investment (FDI) from investment vehicles of Blue Earth Capital AG (BlueEarth), a Switzerland-based global impact investment firm, for an undisclosed equity stake.

This investment was facilitated by Tata Capital Healthcare Fund (TCHF), the healthcare-focused private equity fund of Tata Capital Ltd., reinforcing their collective commitment to enhancing accessible, high-quality kidney care in India. Last year, TCHF invested an equivalent amount in AKC, through a similar equity investment.

Speaking on the partnership, Visalakshi Chandramouli, Managing Partner at Tata Capital Healthcare Fund II said "This collaboration highlights our shared commit...